(Q93105631)

English

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program

scientific article published on 05 September 2019

Statements

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit